Literature DB >> 8786369

Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii.

K J Wesson1, M T Hamann.   

Abstract

Keenamide A (1), a new cytotoxic cyclic hexapeptide, was isolated from the notaspidean mollusk Pleurobranchus forskalii. Its structure was determined by NMR spectral data interpretation and chiral amino acid analysis. Keenamide A (1) exhibited significant activity against the P-388, A-549, MEL-20, and HT-29 tumor cell lines, but was inactive when evaluated against the D6 and W2 Plasmodium falciparum malarial clones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786369     DOI: 10.1021/np960153t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  17 in total

Review 1.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 2.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 3.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

5.  Ribosomal route to small-molecule diversity.

Authors:  Ma Diarey B Tianero; Mohamed S Donia; Travis S Young; Peter G Schultz; Eric W Schmidt
Journal:  J Am Chem Soc       Date:  2011-12-22       Impact factor: 15.419

Review 6.  Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.

Authors:  Guadalupe-Miroslava Suarez-Jimenez; Armando Burgos-Hernandez; Josafat-Marina Ezquerra-Brauer
Journal:  Mar Drugs       Date:  2012-04-26       Impact factor: 6.085

Review 7.  Antitumor peptides from marine organisms.

Authors:  Lan-Hong Zheng; Yue-Jun Wang; Jun Sheng; Fang Wang; Yuan Zheng; Xiu-Kun Lin; Mi Sun
Journal:  Mar Drugs       Date:  2011-10-10       Impact factor: 6.085

8.  Nicotinic Acetylcholine Receptor Partial Antagonist Polyamides from Tunicates and Their Predatory Sea Slugs.

Authors:  Noemi D Paguigan; Jortan O Tun; Lee S Leavitt; Zhenjian Lin; Kevin Chase; Cheryl Dowell; Cassandra E Deering-Rice; Albebson L Lim; Manju Karthikeyan; Ronald W Hughen; Jie Zhang; Randall T Peterson; Christopher A Reilly; Alan R Light; Shrinivasan Raghuraman; J Michael McIntosh; Baldomero M Olivera; Eric W Schmidt
Journal:  ACS Chem Neurosci       Date:  2021-07-02       Impact factor: 5.780

9.  Mollamides B and C, Cyclic hexapeptides from the indonesian tunicate Didemnum molle.

Authors:  Marwa S Donia; Bin Wang; Daniel C Dunbar; Prashant V Desai; Akshay Patny; Mitchell Avery; Mark T Hamann
Journal:  J Nat Prod       Date:  2008-06-11       Impact factor: 4.050

Review 10.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.